FDA ‘yes’ for Fetroja
admin 15th November 2019 Uncategorised 0The company has also submitted a marketing authorisation application for the drug to the European Medicines Agency. More: FDA ‘yes’ for Fetroja Source: News
read more
The company has also submitted a marketing authorisation application for the drug to the European Medicines Agency. More: FDA ‘yes’ for Fetroja Source: News
read moreLast night the annual awards ceremony for the Marketer of the Year, Communications Team of the Year & Sales competitions took place at the gorgeous Chelsea Harbour Hotel. More: Winners announced for the 2019 Marketer of the Year, Communications Team of the Year & Sales Awards
read moreThe therapy, a once-daily oral medicine, was initially approved in the US in May 2019 under the name Qternmet XR. More: AZ bags EU approval for Qtrilmet Source: News
read moreIt’s taken years for Amarin’s fish-oil derivative Vascepa to prove itself as a game-changing treatment for cardiovascular disease. After a “landmark” outcomes trial last year and a hotly anticipated FDA advisory meeting Thursday, Vascepa may now have its ticket to the
read moreContinuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation with plans for a $120 million addition to its facilities in Texas. More: Fujifilm adding 0M facility to its gene therapy operations in
read moreWith a potential approval next year in the up-and-coming NASH field, Intercept is getting into gear. The company is nearly tripling its sales force to 150, working with contract sales reps and talking with payers with the FDA’s permission. More:
read more© 1994 - 2026 B.M. Pharmaceuticals